JP2008520710A5 - - Google Patents

Download PDF

Info

Publication number
JP2008520710A5
JP2008520710A5 JP2007543291A JP2007543291A JP2008520710A5 JP 2008520710 A5 JP2008520710 A5 JP 2008520710A5 JP 2007543291 A JP2007543291 A JP 2007543291A JP 2007543291 A JP2007543291 A JP 2007543291A JP 2008520710 A5 JP2008520710 A5 JP 2008520710A5
Authority
JP
Japan
Prior art keywords
compound
lack
effective amount
pharmaceutical composition
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007543291A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008520710A (ja
JP5036548B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/041888 external-priority patent/WO2006057915A2/en
Publication of JP2008520710A publication Critical patent/JP2008520710A/ja
Publication of JP2008520710A5 publication Critical patent/JP2008520710A5/ja
Application granted granted Critical
Publication of JP5036548B2 publication Critical patent/JP5036548B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007543291A 2004-11-22 2005-11-18 2−メチレン−19,21−ジノル−1α−ヒドロキシ−ビスホモプレグナカルシフェロール Expired - Fee Related JP5036548B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62995804P 2004-11-22 2004-11-22
US60/629,958 2004-11-22
PCT/US2005/041888 WO2006057915A2 (en) 2004-11-22 2005-11-18 2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol

Publications (3)

Publication Number Publication Date
JP2008520710A JP2008520710A (ja) 2008-06-19
JP2008520710A5 true JP2008520710A5 (enExample) 2009-01-15
JP5036548B2 JP5036548B2 (ja) 2012-09-26

Family

ID=36498437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007543291A Expired - Fee Related JP5036548B2 (ja) 2004-11-22 2005-11-18 2−メチレン−19,21−ジノル−1α−ヒドロキシ−ビスホモプレグナカルシフェロール

Country Status (11)

Country Link
US (1) US8604008B2 (enExample)
EP (1) EP1827452B1 (enExample)
JP (1) JP5036548B2 (enExample)
AT (1) ATE499942T1 (enExample)
AU (1) AU2005309820B2 (enExample)
CA (1) CA2588063C (enExample)
DE (1) DE602005026694D1 (enExample)
ES (1) ES2358914T3 (enExample)
MX (1) MX2007006094A (enExample)
NZ (1) NZ555561A (enExample)
WO (1) WO2006057915A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005309820B2 (en) 2004-11-22 2011-06-23 Wisconsin Alumni Research Foundation 2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol
US8222235B2 (en) * 2004-11-22 2012-07-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(20R)-1α-hydroxy-bishomopregnacalciferol
CA2824870C (en) * 2011-06-14 2018-08-14 Wisconsin Alumni Research Foundation 3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666634A (en) * 1984-12-05 1987-05-19 Chugai Seiyaku Kabushiki Kaisha vitamin D3 derivatives having a substituent at 2-position
CA2062520C (en) 1991-03-11 1998-08-11 Hector F. Deluca Synthesis of 1-alpha-hydroxy-secosterol compounds
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
JP2898882B2 (ja) 1993-04-05 1999-06-02 ウイスコンシン アラムナイ リサーチ フオンデーシヨン 2−位に置換基を有する19−ノル−ビタミンd3 化合物
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5891865A (en) * 1996-10-04 1999-04-06 Wisconsin Alumni Research Foundation Treatment of arthritic disease induced by infectious agents
US6392071B1 (en) * 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US5945410A (en) 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US5936105A (en) * 1997-06-13 1999-08-10 Tetrionics, Inc. 14-EPI-19-nor-vitamin D compounds and methods
AU7544501A (en) * 2000-09-08 2002-03-22 Wisconsin Alumni Res Found 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
WO2003051828A2 (en) * 2001-12-13 2003-06-26 Wisconsin Alumni Research Foundation (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6835723B2 (en) * 2001-12-13 2004-12-28 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-1α-hydroxy-bis-homo-pregnacalciferol in crystalline form
US6627622B2 (en) * 2002-02-18 2003-09-30 Wisconsin Alumni Research Foundation (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6566352B1 (en) * 2002-02-18 2003-05-20 Wisconsin Alumni Research Foudation 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
ATE346839T1 (de) * 2002-03-29 2006-12-15 Wisconsin Alumni Res Found Ein verfahren zur herstellung von 1-alpha-hydroxy-2-methylen-19-nor-homopregnacal iferol
NZ545862A (en) * 2003-08-20 2010-01-29 Wisconsin Alumni Res Found 2-Methylene-19-nor-vitamin D2 compounds
WO2005051323A2 (en) 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
AU2005309820B2 (en) 2004-11-22 2011-06-23 Wisconsin Alumni Research Foundation 2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol
AU2005309804B9 (en) * 2004-11-22 2011-12-08 Wisconsin Alumni Research Foundation 2alpha-methyl-19-nor-(20S)-1alpha-hydroxy-bishomopregnacalciferol and its uses
EP1828115A4 (en) * 2004-11-22 2010-05-05 Wisconsin Alumni Res Found 2-METHYLENE-19-NOR (20S) -1ALPHA-HYDROXYTRISHOMOPREGNACALCIFEROL
US8222235B2 (en) * 2004-11-22 2012-07-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(20R)-1α-hydroxy-bishomopregnacalciferol
EP2237837B1 (en) * 2007-12-28 2012-08-22 Wisconsin Alumni Research Foundation (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
CA2710954C (en) * 2007-12-28 2015-07-21 Wisconsin Alumni Research Foundation (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs

Similar Documents

Publication Publication Date Title
JP2010505739A5 (enExample)
JP2009532458A5 (enExample)
JP2008520689A5 (enExample)
JP2005529878A5 (enExample)
JP2008520709A5 (enExample)
JP2008520703A5 (enExample)
JP2008530110A5 (enExample)
JP2007512376A5 (enExample)
JP2008520708A5 (enExample)
CN109843338B (zh) 含有psma抑制剂的18f标记的三唑
JP2010540555A5 (enExample)
EP1666459A3 (en) Aminocyclohexyl ether compounds and uses thereof
JP2010504995A5 (enExample)
JP2008520705A5 (enExample)
JP2008520691A5 (enExample)
CA2597624A1 (en) 2-methylene-19-nor-(20s-24s)-1.alpha.,25-dihydroxyvitamin-d2
JP2008530109A5 (enExample)
JP2011527695A5 (enExample)
JP2008520710A5 (enExample)
JP2011527699A5 (enExample)
CA2588415A1 (en) 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
JP2009533483A5 (enExample)
JP2010504994A5 (enExample)
CA2531505A1 (en) (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
CN1957948A (zh) 改性蒙脱石及其制备方法和其应用